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S T R E S Z C Z E N I E
Metody dydaktyczne wykorzystujące wirtualnych pacjentów wydają się być idealne 
do nauki praktycznych umiejętności niezbędnych do świadczenia usług z zakresu 
opieki farmaceutycznej. Mimo to liczba opublikowanych studiów przypadków szcze-
gółowo opisujących zastosowanie wirtualnych pacjentów w kształceniu studentów 
farmacji czy podczas kursów w ramach szkolenia ciągłego farmaceutów jest zaska-
kująco niska. W niniejszej publikacji został opisany proces tworzenia wirtualnego 
pacjenta jako strategii nauczania. W celu skonstruowania wirtualnego pacjenta wy-
korzystano platformę Decision Simulation, która służy do zgodnego ze standardami 
projektowania i udostępniania rozgałęzionych, narracyjnych scenariuszy przypadków. 
Przygotowany scenariusz przypadku pacjentki z cukrzycą typu 1 został zaprojekto-
wany, aby umożliwić studentom rozwinięcie umiejętności logicznego rozumowania, 
wyciągania wniosków, uzasadniania i podejmowania decyzji dotyczących pacjentów 
w bezpiecznym, wirtualnym środowisku. Większość studentów zaangażowanych 
w testowanie i walidację tej metody uznała ją za bardziej użyteczną i skuteczną niż 
kurs opieki dostarczany za pomocą tradycyjnej metody nauczania. Bazując na do-
świadczeniach z przeprowadzonego eksperymentu podjęto decyzję o wdrożeniu wir-
tualnych pacjentów jako ofi cjalnego elementu programu studiów studentów farmacji 
Collegium Medicum Uniwersytetu Jagiellońskiego. 
Słowa kluczowe: studium przypadku, cukrzyca typu 1, opieka farmaceutyczna, edu-
kacja farmaceutyczna, wirtualny pacjent
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A B S T R A C T
Virtual patients (VPs) based methods seem to be perfect to teach the skills of phar-
maceutical care practice, yet there is a surprisingly small number of the published 
case studies with a detailed description of their use in the undergraduate pharmacy 
curricula or continuing pharmacy education courses. In this paper, we describe the 
development of VP as teaching strategy. The Decision Simulation platform, which is 
a standard-based VP platform for authoring and delivering the branched narrative 
case scenarios was used to construct a VP scenario. The virtual case was designed to 
develop decision-making and reasoning skills. Most of the students, involved in this 
approach testing and validation, found it useful and benefi cial as compared with the 
traditional course. Consequently the VP methodology was introduced as an offi  cial 
part of the pharmacy curriculum.
Key words: case study, diabetes type 1, pharmaceutical care, pharmacy education, 
virtual patient 
Introduction
Pharmaceutical care and VPs are the two key phrases which make a lot of buzz in the world of pharmacy education. A sim-
ple search with the use of the most popular 
internet search engines points to a plethora 
of sites and documents touching upon these 
topics. There is although a surprisingly small 
number of the published case studies with 
a detailed description of their use in the un-
dergraduate pharmacy curricula or continu-
ing pharmacy education courses. In one of 
the recent review publications, Jabbur-Lopes 
and colleagues conducted a literature review 
aiming in the evaluation of the VPs technol-
ogy utilization in pharmacy education. They 
concluded that there were few published 
papers in the fi eld and few patient case sce-
narios available. Authors suggest that there 
is a paucity of examples where VPs were ef-
fectively used, which indicates underuse of 
such methods in pharmacy education (Jab-
bur-Lopes et al., 2012). It was further noticed 
by Cavaco and colleagues (Cavaco&Madeira, 
2012). There are multiple potential reasons 
for such situation, yet probably most obvious 
is hidden behind the word ‘resources’ used 
in the Jabbur-Lopes conclusions section. De-
spite of indisputable benefi ts coming from us-
ing VPs technology, including eff ective teach-
ing of clinical and communications skills, the 
scale of necessary investments in the launch 
of VPs technology and development of virtual 
cases is signifi cant (Marriott, 2007; Noori et al., 
2015; Smith&Benedict 2015; Villaume, Berger, 
Barker, 2006). 
There are various approaches to develop 
virtual cases, from standardized patients to 
high-fi delity human patient simulation (Bene-
dict, 2010; Marken et al., 2010; Mieure et al., 
2010; Noori et al., 2015; Rickles et al., 2009; 
Smithburger et al., 2010; Vyas et al., 2010). 
An example of implemented virtual environ-
ment covering various clinical scenarios and 
3D characters allowing for fl exible interaction 
is a Keele University project (University Keele, 
2016). 
Aim of the project
The aim of this project was to develop interac-
tive, adaptive, competency-based tool for the 
course delivery. The created VP provides stu-
dents with the opportunity to face and man-
age complex clinical situations which demand 
integration and proper use of gained knowl-
edge and skills to deliver evidence-based pa-
tient-centered care. In this paper, we describe 
the development and a case of use of the VP 
as teaching strategy during Pharmaceutical 
Care course in the pharmacy curriculum at 
Jagiellonian University Medical College in Kra-
kow, Poland.
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Virtual patient case study development
Software
The Decision Simulation, LLC, (2012, Uni-
versity of Pittsburgh) platform was used to 
construct a VP scenario. The DecisionSim is 
a standards-based VP platform for authoring 
and delivering the branched narrative case 
scenarios. The simplest case scheme contains 
following elements (Fig. 1): descriptive intro-
duction, decision node, and outcome nodes.
VP case scenario can be composed of un-
limited nodes and branching rules. Five types 
of nodes may be utilized to structure a case: 
(1) narrative, which provides information and 
directs learner to the next, single node; (2) 
branching, which directs learner to the dif-
ferent paths according to the decision made; 
(3) multiple choice, where learner may select 
one, more than one or no answer; each choice 
may be used to determine the further course 
of a case; (4) inquiry, 
where learner may select 
multiple answers; instant 
feedback before continu-
ing is an option (e.g., his-
tory-taking questions); (5) 
text responses, which test 
learner’s knowledge. De-
cisionSim also allows the 
creation of rules directing 
learner to defi ned paths 
depending on previously 
made decisions. Option-
ally, every decision or an-
swer can be scored, and 
counters may be used to 
track user’s performance. Author 
panel allows groups creation 
and advanced management of 
both learners and cases; permis-
sion levels can be assigned to us-
ers, learning objectives can be 
defi ned as well as counters and 
rules. An automatic case vali-
dation tool helps identify and 
fi x potential problems. Reports 
upon specifi c learners sessions 
are available to case authors and managers. 
Reports include the path taken by the user 
(sequential list of nodes that had been visited 
with answers chosen by the learner), counter 
values (scores, number of steps, or amount of 
real time spent to reach a case end-point, to-
tal time based on time assigned to each node 
by the author of case) so that individual learn-
er performance or progress can be monitored 
and assessed.
Case structure assumptions
Our case for a patient with diabetes type 1 is 
composed of over 500 nodes. Its fragments are 
presented in Fig. 2 and Fig. 3. Students were 
allowed to access the virtual case during the 
classes, which lasted 3 hours and 45 minutes. 
This time should have been spent on making 
decisions in DecisionSim software. However, 
the documentation of the pharmaceutical 
care process could have been delivered to the 
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Fig. 1. The scheme of a simple case (source: authors’ own work).
Fig. 2. Introductory elements of the case map (source: authors’ own work).
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Fig. 3. A section of the case map (source: authors’ own work).
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tutors within 10 days. The case can be only 
played forward. Thus the learner cannot go 
back while solving the case nor change previ-
ously made choices. However, solving the case 
can be stopped at any time and resumed later 
on beginning from the last visited node. There-
by, students can come through therapeutic 
guidelines and recommendations of scien-
tifi c societies, read relevant publications or 
discuss possible alternatives with colleagues 
before making fi nal decisions. They were, 
however, encouraged to work individually.
Case construction
Clinical problem
Diabetes type 1 was chosen as a pharmaceuti-
cal care - eligible disease. In the course of this 
chronic disease, the patient’s behavior is di-
rectly linked to a health outcome. Any wrong 
decision or negligence may shortly lead to se-
rious negative health consequences. Patient 
knowledge about the pathophysiology of the 
disease, role of insulin and the lifestyle is cru-
cial to maintaining proper blood glucose level 
and diminish the risk of complications associ-
ated with hyper- and hypoglycemia. Trained 
and cautious pharmacists can detect prob-
lems as well as gaps in patient knowledge. 
However, the time required for this kind of ac-
tivity usually exceeds the time of the routine 
visit of the patient in the pharmacy. Providing 
pharmaceutical care in concordance with He-
pler and Strand defi nition off ers the opportu-
nity to identify and prevent (potential) or re-
solve (real) drug-related problems (DRP). 
Target audience 
Since the proper patient care planning, 
implementing and evaluation require com-
prehensive background knowledge, pharma-
cy students attending mandatory Pharmaceu-
tical Care course in their fi fth study year were 
selected as the target audience for the VP 
case. Completion of prerequisite courses, i.e., 
physiology, pathophysiology, pharmacokinet-
ics, pharmacology, toxicology, pharmacogno-
sy, and epidemiology was required before ad-
mission to this course. The case was designed 
as an optional module of the Pharmaceutical 
Care course. Students were assured that their 
performance during virtual case would not in-
fl uence their general course learning assess-
ment nor grading. However, achieving good 
patient’s outcome would be gratifi ed by some 
extra points in the fi nal course grade. 
Tab. 1. Virtual patient case learning objectives (source: authors’ own work).
Students will be able to
describe insulin-therapy rules in diabetes type 1
defi ne possible complications of diabetes
demonstrate the technique of the insulin administration
demonstrate blood glucose meter use
assess and alter therapeutic regimen to control hyper-/hypoglycaemia 
or co-morbidities
defi ne therapeutic goals for a diabetic patient with the use of guidelines
identify and manage drug-related problems
prepare and execute diabetes monitoring plan for the patient
evaluate the eff ectiveness of insulin therapy
develop a patient education plan
discuss the role of exercise, diet and foot care
monitor patient compliance
describe insulin-therapy rules in diabetes type 1
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Learning objectives
Self-directed learning, when learners work 
individually with limited interaction with the 
tutors, was chosen as a learning model for our 
VP case. The case scenario building started 
from defi ning learning objectives. Completed 
case should result in knowledge and skills 
gain. The learning outcomes for the VP case 
are outlined in Tab. 1. 
The realization of learning objectives was 
evaluated by scoring students’ decisions made 
in a particular situation related to one of the 
learning goals emerged during the course of 
the case. Additionally, students were to doc-
ument whole pharmaceutical care process in 
the in-house documenting paper system.
Patient description
Proposed VP is 17-years old woman, known 
by the pharmacist-student for several years, 
who was recently referred to the community 
pharmacist (student) to the general practi-
tioner with the symptoms of diabetes. After 
diabetes mellitus type 1 diagnosis and short 
hospital treatment for glycaemia stabilization, 
an insulin therapy has been prescribed. Pa-
tient’s parents and herself feel confused and 
uncertain about the disease and its treatment; 
they ask the pharmacist for help. Soon after, 
the patient is diagnosed with depression.
Case scenario
The fi rst decision to take is whether to 
provide pharmaceutical care to the patient 
Tab. 2. Pharmacotherapy issues included into the path without pharmaceutical care (source: authors’ 
own work).
Diabetes specifi c issues Non disease-specifi c issues
General information about the newly diagnosed 
disease, prescribed therapy and diet (patient-
specifi c leafl et expected)
Acne and its complex therapy including OTC 
drugs and diet
Insomnia (lack of the proper glycaemia control) Analgesics choice (aspirin and acetaminophen) 
Damaged insulin pen and expected pharmacist 
reaction
Cracked heel skin (the pharmacist should consider 
fungal infection)
Hypoglycaemia ca. 2h after the morning meal 
(lack of the proper glycaemia control)
OTC/herbal immunostimulant 
or not. Students are given the opportunity to 
refuse pharmaceutical care service to the pa-
tient. However, they are still obliged to deliv-
er standard pharmaceutical service includ-
ing making decisions, providing information 
about dispensed drugs and addressing pa-
tient’s concerns. Regardless the choice, each 
student’s decision entails diff erent conse-
quences which should be tackled. The patient 
generally does not consult the pharmacist’s 
decisions with any other health care special-
ist so that the learner can observe possible ef-
fects of his/her counseling. For example, if the 
student advises discontinuation of the drug, 
the patient will usually follow the instruc-
tions. Moreover, to enhance the collabora-
tion between the pharmacist and physicians 
some problems are addressed by the medical 
practitioner, who requests additional informa-
tion from the pharmacist about the scientifi c 
grounds of pharmacist’s decision or counsel. 
Path without pharmaceutical care
A decision on giving up the full pharmaceuti-
cal care pathway does not exempt pharmacist 
from liability for his/her patients. Therefore, 
even that it was decided to allow learners not 
to follow the full pharmaceutical care process, 
some of the commonly met issues, which 
should be addressed by the pharmacist, were 
encoded in a parallel path. With or without 
pharmaceutical care, wrong decisions could 
have been made or wrong advice could have 
been given by the learner, resulting in serious 
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health consequences including hospitaliza-
tion. 
The medical and pharmaceutical problems 
covered in the current path can be divided 
into two separate groups: the fi rst one touch-
ing mainly upon the diabetes-specifi c issues 
and the second one, which was more general 
and non-disease-specifi c (Tab. 2). The pharma-
cist is neither expected to track back the phar-
macotherapy history nor to plan specifi cally 
further services. The problems faced require 
good general pharmaceutical knowledge 
yet do not exceed the capability of a prop-
erly prepared and well-trained pharmacist.
Path with pharmaceutical care 
If the full pharmaceutical care path is chosen, 
the student is supposed to collect patient-
specifi c information, assess drug-related 
problems, establish therapeutic goals and 
specify monitoring plan. During the consecu-
tive visits, the student is faced with therapeu-
tic complications, emerging DRPs, and patient 
inquiries. The case covers almost 4 months 
of continuous pharmaceutical care process 
(from October 28th until 10th of February next 
year) with at least 6 visits to the pharmacy. 
However, the total number of visits depends 
on the decisions made by the student. Anti-
diabetic therapy consists of NPH insulin once 
daily in the evening (8 IU) and regular insulin 
three times daily before meals (10 IU before 
breakfast, 6 IU before dinner and 8 IU before 
supper). Other drugs used by the patient oc-
casionally are acetaminophen and drotaver-
ine for menstrual pain. The patient monitors 
her blood glucose levels regularly and keeps 
a log of the readings. Case scenario includes 
following elements:
1. Initial interview
Medical history is an important initial step of 
the pharmaceutical care process. The learner 
decides which questions should be asked at 
the very beginning, during the fi rst meeting. 
If student omits any essential questions (e.g., 
about pharmacotherapy), he/she is not capa-
ble of informed decision making. 
2. Blood glucose monitoring and special is-
sues management
The student is supposed to analyze blood glu-
cose results according to current guidelines. 
The student should also assess the appropri-
ateness of blood glucose monitoring tech-
nique and insulin injection technique with 
the preparation of injection site, based on the 
description obtained from the patient. 
Coordination of the insulin injections with 
meals is crucial to ensure the safety and ef-
fectiveness of antidiabetic therapy. The pa-
tient reports morning symptoms suggesting 
hypoglycaemia. Learner should ask addition-
al questions, which let him/her fi nd the most 
probable reason - omitting or delaying break-
fast after insulin injection. Learner should re-
mind the patient that insulin must be inject-
ed 15 minutes before meal and food must be 
taken if insulin is administered to avoid hypo-
glycaemia. 
3. Patient counseling for minor ailments
The case covers also issues not specifi cally re-
lated to diabetes, putting emphasis on various 
aspects of pharmacotherapy and drug-relat-
ed problems. Patient presents with symptoms 
of upper respiratory tract infection, including 
a productive cough, high fever, headache, 
sore throat and trouble breathing due to rhi-
nitis. Apart from dispensing a prescription for 
antibiotic, pharmacist should also suggest 
medical products relieving these symptoms, 
taking into consideration that:
• some drugs contain sugar, and patients 
with diabetes should not use them (e.g., 
some lozenges, syrups),
• some ingredients may alter blood glucose 
control, like acetylsalicylic derivatives,
• the patient suff ers from a productive 
cough though antitussives and combined 
drugs with antitussive ingredients are 
contraindicated unless a cough disturbs 
night sleep,
• there is no indication for dispensing an an-
tiallergic drug (e.g., nasal dimetindene),
• pharmacist should rely on evidence-
based medicine and should not counsel 
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drugs containing ingredients eff ective-
ness of which was not scientifi cally prov-
en in a particular indication (for the treat-
ment of upper respiratory tract infection, 
e.g., low doses of vitamin C, codein, herbal 
drugs (Sexton&McClain, 2016), 
• some substances interact with sertra-
line used by the patient for depression 
(naproxen, acetylsalicylic acid - increased 
toxicity and risk of upper gastrointesti-
nal bleeding; dextromethorphan increas-
es the serotonin level and should not be 
used concomitantly).
The learner should also deal with a pre-
scription for antibiotics. A probiotic product 
may be suggested together with information 
about its proper use. Learner should also clar-
ify the prescription for inhaled formoterol for 
upper respiratory tract infection with breath-
ing diffi  culties due to rhinitis because there is 
no evidence that inhaled beta2-agonists im-
prove symptoms in patients without any ob-
structive respiratory disease (Becker et al., 
2015). 
4. Compliance monitoring
Non-adherence is a vital problem among pa-
tients, often undiscovered in standard medical 
care procedures. Pharmaceutical care requires 
that every supply of the patient’s medications 
is documented. Therefore pharmacist should 
identify and resolve this kind of pharmaco-
therapy issue. Presented case includes non-
adherence problems regarding insulin, test 
strips and antidepressants. Learner should 
remind the patient that current drugs supply 
is running out. Otherwise, the patient has to 
arrange an emergency visit. 
5. Referral
Several times, the learner may decide to refer 
the patient to a physician without the specifi c 
need (for example referral for the prescription 
while current drugs supply is not going to run 
out or referral for switching or discontinuing 
of medicine while another action e.g., cau-
tious blood glucose monitoring would be suf-
fi cient). These decisions lead to unnecessary 
medical resources involvement and a waste 
of patient time, so the learner receives nega-
tive feedback either from the physician or the 
patient. Negative feedback from the physician 
is also given when learner makes a decision 
which is not within his/her professional com-
petence, e.g., changing insulin dosage with-
out prior physician consultation.
Depending on the path taken by the 
student the several problems can arise 
Pharmaceutical care should result in the im-
provement or, at least, maintenance of a cur-
rent level of quality of life. The learner may 
ask the patient to fi ll in SF36v.2 quality of life 
questionnaire, which is a valid instrument to 
assess the physical, mental and social per-
formance of the respondent (Ware, Kosinski, 
Dewey, 2002). This may be particularly use-
ful in patients with diabetes as depression 
is a common comorbidity which infl uences 
patient’s life quality and health outcomes 
(Johnson et al., 2013). Based on the knowl-
edge from previous year courses, the learner 
should interpret the results and incorporate 
them into the pharmaceutical care plan. The 
questionnaires combined with information 
from anamnesis show that the patient may be 
depressed. Therefore she should be referred 
to the specialist. Otherwise, to improve the 
mood the patient begins using marijuana. Be-
sides its addictive potential, the major concern 
of pharmacist should be its possible hypogly-
cemic eff ect (Penner, Buettner, Mittleman, 
2013). Learner should encourage the patient 
to discontinue the drug and refer the patient 
to the specialist. Postponing referral results in 
hospitalization due to hypoglycaemia.
A woman with diabetes should be in-
formed that it is better to plan the pregnancy 
to avoid complications from high blood glu-
cose levels. It is recommended that a wom-
an, who does not wish to conceive and is 
sexually active, use eff ective contraception. 
The patient is at reproductive age and has 
a boyfriend so the pharmacist should raise 
this problem. In Poland hormonal contra-
ception is available only with a prescription. 
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Therefore, the patient should be referred by 
the learner to the gynaecologist, otherwise, 
at the end of the case, the patient becomes 
pregnant.
After referral to the gynaecologist the pa-
tient presents with a prescription for com-
bined oral contraceptive pills. During the con-
secutive visits, a learner has several occasions 
to modify unreasonably the gynaecologist 
orders (e.g., discontinuation of a drug, intro-
ducing 7-day long break while the patient has 
medication with four placebo pills) which may 
result in pregnancy. Learner should also ad-
vise additional contraception during and the 
seven days after amoxicillin is administered 
for upper respiratory tract infection. Other-
wise, the patient gets pregnant.
Learner is supposed to prepare the patient 
for the winter holidays away from home, in-
cluding advice on storage of the insulin prep-
arations, additional supply before leave to se-
cure continuity of pharmacotherapy, as well 
as advice on dealing with regular insulin am-
pule, which becomes cloudy probably due to 
low temperature.
Many compounds used for medical and 
recreational purposes may aff ect blood glu-
cose control. However, some of them may be 
used by diabetic patients. When dispensing 
fl uoxetine, ciprofl oxacin and oral contracep-
tives learner should advise additional glycae-
mia monitoring and reporting any blood glu-
cose levels irregularities; additional monitor-
ing should also be advised when the patient 
presents with signs of infection and with pre-
scription for antibiotics (for urinary tract infec-
tion, for upper respiratory tract infection) be-
cause the infection, especially with fever, may 
aff ect blood glucose control. Otherwise, the 
patient experiences symptoms of hypo- or hy-
perglycaemia. In the case of urinary tract in-
fection treated with ciprofl oxacin, unless the 
learner points out the potential additive hy-
perglycemic eff ect and advises additional 
monitoring of blood glucose level, the patient 
presents with symptoms of hyperglycaemia. 
Disregarding symptoms result in hospitaliza-
tion due to diabetic ketoacidosis.
Presented case also emphasizes econom-
ic aspects of pharmacotherapy. Test strips, 
which are going to run out within few days, 
may be dispensed legally without prescrip-
tion, however, their cost is almost 15-fold 
higher as compared to test strips dispensed 
with a valid prescription. Learner should refer 
the patient to the physician rather than dis-
pense test strips at full cost to the patient.
Conclusions
Virtual laboratory for pharmaceutical care 
practicing was created allowing students 
to test their professional skills in the simula-
tion of real situations. The virtual case was 
designed to develop decision-making and 
reasoning skills, which was accomplished 
through including numerous decision points 
aff ecting patient’s care outcomes. Learners 
receive immediate feedback on the impact 
of their decisions. However, some symptoms 
or complications may occur in the longer pe-
riod as a result of wrong decision or omission. 
Simulation of pharmaceutical care process for 
diabetic patient lasting four months can be 
realized in about 4 hours. However, this time 
did not cover the time needed to document 
the whole process. 
General student’s perception of the teach-
ing/learning method according to our experi-
ence is positive. However, their opinions were 
expressed only orally, and neither satisfaction 
nor the method or case scenario itself wasn’t 
evaluated with written questionnaires. The 
students claimed the VP to be challenging 
and demanding, but they enjoyed the learn-
ing method and suggested it should be em-
bedded into the traditional teaching scheme 
of the Pharmaceutical Care course. 
As anatomy, physiology, pathophysiolo-
gy, medicinal chemistry, pharmacokinetics, 
pharmacognosy, toxicology, epidemiology, 
and pharmacology courses were Pharmaceu-
tical Care course prerequisites defi ned in the 
syllabus, we assumed that students had es-
sential knowledge and skills, but they found 
it diffi  cult to integrate the previously gained 
Virtual patient case studies in pharmacy education – how to make it work and worth
information and use them in real life situa-
tions. The traditional, subject-based teaching 
might be the reason; virtual patient case stud-
ies in pharmacy education was probably the 
fi rst time during their undergraduate educa-
tion when students had to focus on a specifi c, 
individual patient and not just on a drug. Dur-
ing the case, many students made decisions 
which did not belong to the professional com-
petence of pharmacists. These problems indi-
cate the need to pay more attention to the 
drug-related problems as well as to the legal 
aspects of being a pharmacist in the pharma-
ceutical care teaching process.
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